About Biolog
Biolog is a company based in Hayward (United States) founded in 1984. Biolog has raised $33.62 million across 6 funding rounds from investors including HHS, Broadoak Capital Partners and Research Corporation Technologies. The company has 27 employees as of December 31, 2022. Biolog has completed 3 acquisitions, including Anaerobesystems, MIDI Labs and Microbial Identification. Biolog offers products and services including Odin ID Station, EcoPlate, Anaerobic Chambers, and GEN III Test Panel. Biolog operates in a competitive market with competitors including 10X Genomics, Mission Bio, Cellares, LUMICKS and LevitasBio, among others.
- Headquarter Hayward, United States
- Employees 27 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Biolog, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$33.62 M (USD)
in 6 rounds
-
Latest Funding Round
$16.12 M (USD), Series A
Feb 10, 2025
-
Investors
HHS
& 3 more
-
Employee Count
27
as on Dec 31, 2022
-
Investments & Acquisitions
Anaerobesystems
& 2 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biolog
Biolog offers a comprehensive portfolio of products and services, including Odin ID Station, EcoPlate, Anaerobic Chambers, and GEN III Test Panel.
System for microbial identification and characterization
Tool for monitoring environmental microbial communities
Provides oxygen-free environments for microbial culture
Identifies aerobic bacteria for research applications
People of Biolog
Unlock access to complete
Funding Insights of Biolog
Biolog has successfully raised a total of $33.62M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $16.12 million completed in February 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Biolog
Biolog has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Broadoak Capital Partners and Research Corporation Technologies.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Research Corporation Technologies is engaged in licensing biomedical technologies.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Investment banking services are offered in the United States.
|
Locked | Locked | Locked |
Investor details for Biolog
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biolog
Biolog has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Anaerobesystems, MIDI Labs and Microbial Identification.
Investment portfolio details for Biolog
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Microbial testing and identification services are offered by MIDI Labs.
|
Locked | Locked | 1996 | Locked | |
|
Chemical data analysis and microbial identification solutions are offered.
|
Locked | Locked | 1991 | Locked | |
|
Anaerobic chambers and pre-reduced culture media are manufactured.
|
Locked | Locked | 0 | Locked |
Complete acquisition details for Biolog
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Biolog
Detailed financials for Biolog
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biolog Comparisons
Peer comparison for Biolog
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biolog
Biolog operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as 10X Genomics, Mission Bio, Cellares, LUMICKS and LevitasBio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Instrument systems for genomic research and sequencing libraries are developed.
|
|
| Locked | Locked | Locked |
Single-cell multi-omics platform is provided for genotypic and phenotypic analysis.
|
|
| Locked | Locked | Locked |
Medical devices for cell-based therapy manufacturing are produced.
|
|
| Locked | Locked | Locked |
Optical tweezers instruments for single-molecule analysis are manufactured.
|
|
| Locked | Locked | Locked |
Single-cell imaging platform developed via magnetic levitation technology.
|
Detailed competitors of Biolog
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biolog
Complete news archive for Biolog
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biolog
Biolog was founded in 1984 and raised its 1st funding round 23 years after it was founded.
Biolog is headquartered in Hayward, United States. It is registered at Hayward, California, United States.
Biolog is a funded company, having raised a total of $33.62M across 6 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Biolog is 27.
Founded in 1984 and headquartered in Hayward, United States, Biolog focuses on biotechnology solutions for microbial identification and analysis. Technologies such as the Microbial ID System are utilized to identify over 2,900 species of aerobic and anaerobic bacteria, yeasts, and fungi. Chromogenic media like Rainbow Agar, EcoPlates for community profiling, and Phenotype MicroArrays for parallel phenotype assessment are offered. Research services based on Phenotype MicroArrays are also conducted.
Biolog's top competitors include 10X Genomics, Mission Bio and Cellares.
Biolog offers Odin ID Station, EcoPlate, Anaerobic Chambers, and GEN III Test Panel.
Biolog has made 3 acquisitions, including Anaerobesystems, MIDI Labs, and Microbial Identification.
Biolog has 4 investors. Key investors include HHS, Broadoak Capital Partners, Research Corporation Technologies, and Redfund Capital.